The first Rubius Therapeutics trade was made in Q2 2020.
Since then Jim Simons bought shares six more times and sold shares on five occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Rubius Therapeutics anymore.
Avg closing price
Price range
Sold -200k shares
Q1 2023
Avg closing price
$0.15
Price range
$0.02
-
$0.34
Increased shares by 55.7% (+71.6k shares)
Q4 2022
Avg closing price
$0.27
Price range
$0.14
-
$0.45
Sold 84.4% shares (-698k shares)
Q3 2022
Avg closing price
$0.75
Price range
$0.43
-
$1.29
Increased shares by 617.0% (+711k shares)
Q2 2022
Avg closing price
$1.68
Price range
$0.79
-
$5.98
Increased shares by 62.5% (+44.3k shares)
Q1 2022
Avg closing price
$6.35
Price range
$4.25
-
$10.40
Increased shares by 246.1% (+50.5k shares)
Q4 2021